caa a22 4500 60553960X CHVBK 20210128100907.0 cr unu---uuuuu 210128e20150701xx s 000 0 eng 10.1007/s10396-015-0621-9 doi (NATIONALLICENCE)springer-10.1007/s10396-015-0621-9 Bioprosthetic tricuspid valve replacement in carcinoid heart disease from primary ovarian carcinoid tumor [Elektronische Daten] [Toshimitsu Tsugu, Shiro Iwanaga, Mitsushige Murata, Keiichi Fukuda] Carcinoid heart disease (CHD) commonly occurs in association with primary gastrointestinal tract carcinoid tumors with hepatic metastases. Unlike primary gastrointestinal tract carcinoid tumors, primary ovarian carcinoid tumors may cause CHD without hepatic metastases, accounting for only 0.3% of all carcinoid tumors. Only 37 cases of CHD from primary ovarian carcinoid tumors have been reported. We present a case of CHD in which tricuspid valve thickening and shortening led to reduced valve mobility with the resulting severe tricuspid regurgitation. Considering these characteristics of an abnormal tricuspid valve, we suspected CHD, but prosthetic valve replacement was performed without sufficient systemic examination before surgery. Two years after valve replacement, the patient underwent excision of a mass in the lower abdomen, which was diagnosed as an ovarian carcinoid tumor by histopathological examination. The patient has been observed for more than 3years after tricuspid valve replacement. She has not experienced bioprosthetic valve leaflet degeneration or dysfunction, although it has been reported that bioprosthetic valves may degenerate in patients with carcinoid tumors. Sufficient systemic examinations should be performed to explore the cause of disease. The Japan Society of Ultrasonics in Medicine, 2015 Carcinoid heart disease nationallicence Echocardiography nationallicence Bioprosthetic valve replacement nationallicence Cartinoid tumor nationallicence Tsugu Toshimitsu Department of Cardiology, School of Medicine, Keio University, Tokyo, Japan aut Iwanaga Shiro Department of Cardiology, Saitama International Medical Center, Saitama, Japan aut Murata Mitsushige Department of Laboratory Medicine, School of Medicine, Keio University, Tokyo, Japan aut Fukuda Keiichi Department of Cardiology, School of Medicine, Keio University, Tokyo, Japan aut Journal of Medical Ultrasonics Springer Japan 42/3(2015-07-01), 401-403 1346-4523 42:3<401 2015 42 10396 https://doi.org/10.1007/s10396-015-0621-9 text/html Onlinezugriff via DOI BK010053 XK010053 XK010000 Metadata rights reserved Springer special CC-BY-NC licence nationallicence 1 research-article jats NATIONALLICENCE NATIONALLICENCE NL-springer NATIONALLICENCE 856 40 https://doi.org/10.1007/s10396-015-0621-9 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Tsugu Toshimitsu Department of Cardiology, School of Medicine, Keio University, Tokyo, Japan aut NATIONALLICENCE 700 1- Iwanaga Shiro Department of Cardiology, Saitama International Medical Center, Saitama, Japan aut NATIONALLICENCE 700 1- Murata Mitsushige Department of Laboratory Medicine, School of Medicine, Keio University, Tokyo, Japan aut NATIONALLICENCE 700 1- Fukuda Keiichi Department of Cardiology, School of Medicine, Keio University, Tokyo, Japan aut NATIONALLICENCE 773 0- Journal of Medical Ultrasonics Springer Japan 42/3(2015-07-01), 401-403 1346-4523 42:3<401 2015 42 10396